Birth weight is associated with the IGF-1 response to GH in children: Programming of the anabolic action of GH?

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 8, 2015, Pages 2972-2978

  Donzeau, Aurélie ^a   Bouhours Nouet, Natacha ^a   Fauchard, Mathilde ^a   Decrequy, Anne ^a   Mathieu, Elisabeth ^a   De Casson, Florence Boux ^a   Gascoin, Geraldine ^a   Coutant, Régis ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FATTY ACID; HUMAN GROWTH HORMONE; INSULIN; SOMATOMEDIN C; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ARTICLE; BIRTH WEIGHT; BODY COMPOSITION; BODY FAT; BODY FAT PERCENTAGE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FETUS GROWTH; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE SENSITIVITY; HORMONE SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SCHOOL CHILD; SHORT STATURE; CLINICAL TRIAL; DRUG EFFECTS; EMBRYO DEVELOPMENT; FETAL GROWTH RETARDATION; GROWTH DISORDERS; METABOLISM; PHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; BIRTH WEIGHT; BLOOD GLUCOSE; BODY COMPOSITION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EMBRYONIC DEVELOPMENT; FEMALE; FETAL GROWTH RETARDATION; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE;

EID: 84939163248     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1603     Document Type: Article

References (40)

1. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989;298:564-567.
2. Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab. 2002;13:364-368.
3. Albertsson-Wikland K, Boguszewski M, Karlberg J. Children born small-for-gestational age: postnatal growth and hormonal status. Horm Res. 1998;49(suppl 2):7-13.
4. Verkauskiene R, Jaquet D, Deghmoun S, Chevenne D, Czernichow P, Lévy-Marchal C. Smallness for gestational age is associated with persistent change in insulin-like growth factor I (IGF-I) and the ratio of IGF-I/IGF-binding protein-3 in adulthood. J Clin Endocrinol Metab. 2005;90:5672-5676.
5. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation. 2002;106:939-944.
6. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2004;89:114-120.
7. Rogers I, Metcalfe C, Gunnell D, Emmett P, Dunger D, Holly J. 2006 Insulin-like growth factor-I and growth in height, leg length, and trunk length between ages 5 and 10 years. J Clin Endocrinol Metab. 2006;91:2514-2519.
8. Ben-Shlomo Y, Holly J, McCarthy A, et al. An investigation of fetal, postnatal and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood. Clin Endocrinol (Oxf). 2003;59:366-373.
9. Paajanen TA, Oksala NK, Kuukasjärvi P, Karhunen PJ. Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis. Eur Heart J. 2010;31:1802-1809.
10. Nelson CP, Hamby SE, Saleheen D, et al. Genetically determined height and coronary artery disease. N Engl J Med. 2015;372:1608-1618.
11. Jensen RB, Chellakooty M, Vielwerth S, et al. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: does insulin-like growth factor-I play a role? Horm Res. 2003;60(suppl 3):136-148.
12. Job JC, Chatelain P, Rochiccioli P, Ponte C, Olivier M, Sagnard L. Growth hormone response to a bolus injection of 1-44 growth-hormone-releasing hormone in very short children with intrauterine onset of growth failure. Horm Res. 1990;33:161-165.
13. Woods KA, van Helvoirt M, Ong KK, et al. The somatotropic axis in short children born small for gestational age: relation to insulin resistance. Pediatr Res. 2002;51:76-80.
14. De Waal WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone. Clin Endocrinol (Oxf). 1994;41:621-630.
15. Harrela M, Koistinen H, Kaprio J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest. 1996;98:2612-2615.
16. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.
17. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13-24.
18. Usher R, McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr. 1969;74:901-910.
19. Sempé M, Pedron G, Roy-Pernot MP. Auxologie, Méthodes et Séquences. Paris: Théraplix Public; 1979.
20. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr. 1991;45:13-21.
21. Achermann JC, Hamdani K, Hindmarsh PC, Brook CG. Birth weight influences the initial response to growth hormone treatment in growth hormone-insufficient children. Pediatrics. 1998;102:342-345.
22. Leger J, Levy-Marchal C, Bloch J, et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. BMJ. 1997;315:341-347.
23. Ranke MB, Lindberg A. Predicting growth in response to growth hormone treatment. Growth Horm IGF Res. 2009;19:1-11.
24. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359:61-73.
25. Carroll PV, Christ ER, Bengtsson BA, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab. 1998;83:382-395.
26. Gleeson HK, Lissett CA, Shalet SM. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. J Clin Endocrinol Metab. 2005;90:1061-1067.
27. Bouhours-Nouet N, Gatelais F, Boux de Casson F, Rouleau S, Coutant R. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature. J Clin Endocrinol Metab. 2007;92:629-635.
28. Martha PM Jr, Reiter EO, Davila N, Shaw MA, Holcombe JH, Baumann G. The role of body mass in the response to growth hormone therapy. J Clin Endocrinol Metab. 1992;75:1470-1473.
29. Fisker S, Vahl N, Jorgensen JO, Christiansen JS, Orskov H. Abdominal fat determines growth hormone-binding protein levels in healthy non-obese adults. J Clin Endocrinol Metab. 1997;82:123-128.
30. Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J Clin Endocrinol Metab. 2004;89:1031-1044.
31. Yakar S, Liu JL, Stannard B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA. 1999;96:7324-7329.
32. Mohan S, Richman C, Guo R, et al. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology. 2003;144:929-936.
33. Stratikopoulos E, Szabolcs M, Dragatsis I, Klinakis A, Efstratiadis A. The hormonal action of IGF1 in postnatal mouse growth. Proc Natl Acad Sci USA. 2008;105:19378-19383.
34. Ohlsson C, Mohan S, Sjogren K, et al. The role of liver-derived insulin-like growth factor-I. Endocr Rev. 2009;30:494-535.
35. Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, et al. Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM. Diabetologia. 1996;39:1498-1504.
36. Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KKY. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab. 2000;85:4712-4720.
37. Thankamony A, Capalbo D, Marcovecchio ML, et al. Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting. J Clin Endocrinol Metab. 2014;99:2198-2207.
38. Lee PD, Durham SK, Martinez V, Vasconez O, Powell DR, Guevara-Aguirre J. Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone. J Clin Endocrinol Metab. 1997;82:2266-2274.
39. Coutant R, de Casson FB, Rouleau S, et al. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents. J Clin Endocrinol Metab. 2004;89:6185-6192.
40. Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab. 1997;82:2423-2428.